CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord
Open Access
- 16 April 2014
- journal article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 11 (1) , 75
Abstract
Previous studies have demonstrated that chemokine CXCL12 and its receptor CXCR4 are critical for pain sensitization, but the mechanisms involved are not clear. In this study, we investigated the specific cellular mechanisms of CXCL12/CXCR4 chemokine signaling in the development and maintenance of bone cancer pain after tumor cell implantation (TCI).Keywords
This publication has 60 references indexed in Scilit:
- CXCR4 signaling mediates morphine-induced tactile hyperalgesiaBrain, Behavior, and Immunity, 2011
- Targeting Astrocyte Signaling for Chronic PainNeurotherapeutics, 2010
- Chemokines, neuronal–glial interactions, and central processing of neuropathic painPharmacology & Therapeutics, 2010
- MAP kinase and painBrain Research Reviews, 2009
- Pathological and protective roles of glia in chronic painNature Reviews Neuroscience, 2009
- Phospholipase Cβ3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic painProceedings of the National Academy of Sciences, 2008
- Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiologyProgress in Neurobiology, 2008
- Chemokines and the pathophysiology of neuropathic painProceedings of the National Academy of Sciences, 2007
- CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathyBrain, Behavior, and Immunity, 2007
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983